Organism burden, toxin concentration, and lactoferrin concentration do not distinguish between clinically significant...

Area of Science:

• Medical diagnostics
• Infectious diseases
• Microbiology

Background:

• Clostridium difficile infection (CDI) diagnosis relies on detecting the organism or its toxins.
• Overdiagnosis of CDI occurs, particularly in patients with mild diarrhea, leading to unnecessary treatment.
• Identifying clinically significant CDI is crucial for accurate diagnosis and patient management.

Purpose of the Study:

• To evaluate four biomarkers as surrogates for clinically significant diarrhea (≥ 3 episodes in 24 hours) in Clostridium difficile PCR-positive patients.
• To assess organism burden, toxin A and B concentrations, and fecal lactoferrin levels in relation to diarrhea severity.
• To determine the utility of these biomarkers in differentiating clinically significant CDI.

Main Methods:

• A case-control study involving 59 Clostridium difficile PCR-positive patients with clinically significant diarrhea and 59 controls without.
• Measurement of organism burden via tcdB cycle threshold values.
• Quantification of toxin A and B concentrations.
• Assay of fecal lactoferrin concentrations.

Main Results:

• No significant differences in organism burden (tcdB cycle threshold) or toxin A and B concentrations between groups.
• Fecal lactoferrin concentrations were significantly higher in patients with clinically significant diarrhea (P=0.05).
• Lactoferrin alone could not sufficiently classify patients based on diarrhea severity.

Conclusions:

• Current biomarkers, including organism burden and toxin levels, are insufficient to differentiate clinically significant Clostridium difficile infection from mild diarrhea.
• Fecal lactoferrin shows potential but lacks the specificity for accurate patient classification.
• Interventions to restrict C. difficile testing to patients with clinically significant diarrhea are necessary to enhance diagnostic accuracy.